Health Care · Pharmaceutical Preparations · Nasdaq · CIK 1746466 · FYE Dec 31 · Prices AT CLOSE 2026-07-29 (USD) — end-of-day, never a live or intraday quote
Last $2.28Day −1.72%Mkt cap $144M1Y +470.0%Off 52W high −35.6%Vol (1Y) 164.4%
Daily closing price, split-adjusted to the current basis; 3y shown of 1,954 bars on file. Sampled to 240 points — every point is a real close, none averaged. Price return, not total return (dividends excluded). Source marketstack.
| Short interest8.8% of sh out |
| Days to cover4.5d |
| 13F net flow (QoQ)−1.67% |
| Top-10 13F concentration86.1% |
| Next report (est.)2026-08-20 |
Short interest is FINRA semi-monthly, settlement 2026-07-15. 13F figures are quarterly filings, period 2026-Q1 — a lower bound on true ownership.
| Sales (TTM)$41.1M |
| Earnings (TTM)-$19.1M |
| ROE−94.0% |
Screener basis: ratios from the latest reported fiscal year; Sales/Earnings are trailing twelve months in the reporting currency (USD). The P/E is a trailing FULL-YEAR P/E, not TTM. Missing lines are absent from the filings, never imputed.
| YTD+47.1% |
| 1Y+470.0% |
| 3Y+208.1% |
| 5Y−58.9% |
| Since incept. (ann.)−20.8% |
Total return through 2026-07-29 · series begins 2018-10-12. Only the windows this history actually covers are shown.
| Ann. volatility (1Y)164.4% |
| Ann. volatility (3Y)132.8% |
| Sharpe (1Y)1.68 |
| Sharpe (3Y)0.88 |
| Max drawdown (1Y)−57.8% |
| Max drawdown (3Y)−90.3% |
| Beta (3Y vs SPY)3.07 |
Daily simple returns, annualized; drawdown is peak-to-trough within the window. Beta is the OLS slope of monthly returns on SPY's over three years. Each figure is labeled by the window it was measured over — they are not comparable across windows.
| Manager | Shares | Value | % sh out | QoQ |
|---|---|---|---|---|
| JANUS HENDERSON GROUP PLC | 6.5M | $13M | 10.27% | +10.8% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 5.3M | $11M | 8.43% | +0.0% |
| Decheng Capital LLC | 4.4M | $9M | 7.03% | +0.0% |
| ADAR1 Capital Management, LLC | 3.7M | $7M | 5.89% | −33.5% |
| Woodline Partners LP | 3.5M | $7M | 5.54% | +0.0% |
| Aberdeen Group plc | 3.4M | $7M | 5.30% | +41.7% |
| RA CAPITAL MANAGEMENT, L.P. | 3.1M | $6M | 4.90% | new |
| VANGUARD CAPITAL MANAGEMENT LLC | 1.8M | $4M | 2.82% | new |
Reported 13F long positions as filed for 2026-Q1 (change vs 2025-Q4). 13F covers US-listed long equity only — the sum is a LOWER BOUND on institutional ownership, never a total.
| Period end | Reported | EPS | EPS YoY | Revenue | Rev YoY |
|---|---|---|---|---|---|
| 2026-03-31 | 2026-05-13 | −$0.06 | — | — | — |
| 2025-09-30 | 2025-11-13 | −$0.06 | — | — | — |
| 2025-06-30 | 2025-08-04 | −$0.16 | −1700.0% | — | — |
| 2025-03-31 | 2025-04-24 | −$0.24 | — | — | — |
EPS and revenue as reported in this filer's own XBRL — our extraction of the filings, not a vendor consensus feed, and never a beat/miss claim (we carry no estimates). YoY compares the same fiscal quarter a year earlier. Next report 2026-08-20 is ESTIMATED from filing cadence (median gap 99d) — not company-confirmed.
